Abstract
Pleural effusion (PE) is a common medical concern, often requiring thoracentesis for a definitive diagnosis. An elevated pleural fluid adenosine deaminase (ADA) may indicate tuberculosis, but this is not always the case. This study aimed to evaluate the accuracy of biomarkers determined in pleural fluid and propose a new diagnostic strategy for PE in patients with high levels of ADA in pleural fluid. This retrospective analysis studied patients with PE who received thoracentesis for the first time with an ADA level of > 33 U/L in the pleural fluid analysis at two tertiary hospitals from March 2019 to March 2023. Demographic and clinical data, as well as pleural fluid biomarkers and their ratios, were studied and compared between different PE groups, and a decision tree was developed. During the study period, 259 patients were enrolled, with four different types of PE: parapneumonic (PPE) 155, tuberculosis (TPE) 41, malignant (MPE) 50, and miscellaneous 13. Biomarkers and their ratios performed well in the differential diagnosis of PE, with the LDH/ADA ratio distinguishing between PPE and non-PPE with sensitivity and specificity of 98.06% and 98.08%, respectively. The combination of LDH/ADA ratio, ADA, and mononuclear cell percentage was identified as important factors for creating a decision tree with an overall accuracy of 89.96%. The pleural fluid LDH/ADA ratio was a useful diagnostic for distinguishing PPE from non-PPE, and a decision tree with an accuracy of 89.96% was created to differentiate the four forms of PE in clinical situations.
Similar content being viewed by others
References
Lee YG, Light RW. Future directions in pleural disease. Textbook of Pleural Diseases: CRC Press; 2016. p. 651–7.
Ferreiro L, Toubes ME, San José ME, Suárez-Antelo J, Golpe A, Valdés L. Advances in pleural effusion diagnostics. Expert Rev Respir Med. 2020;14:51–66.
Light RW, Macgregor MI, Luchsinger PC, Ball WC. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77:507–13.
Porcel JM. Biomarkers in the diagnosis of pleural diseases: a 2018 update. Ther Adv Respir Dis. 2018;12:1753466618808660.
Liang QL, Shi HZ, Wang K, Qin SM, Qin XJ. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med. 2008;102:744–54.
Aggarwal AN, Agarwal R, Sehgal IS, Dhooria S. Adenosine deaminase for diagnosis of tuberculous pleural effusion: a systematic review and meta-analysis. PLoS ONE. 2019;14: e0213728.
Zhang X, Meng Q, Miao R, Huang P. The diagnostic value of T cell spot test and adenosine deaminase in pleural effusion for tuberculous pleurisy: a systematic review and meta-analysis. Tuberculosis (Edinb). 2022;135: 102223.
Shaw JA, Irusen EM, Diacon AH, Koegelenberg CF. Pleural tuberculosis: a: concise clinical review. Clin Respir J. 2018;12:1779–86.
Manuel Porcel J, Vives M, Esquerda A, Ruiz A. Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions. Respir Med. 2006;100:933–7.
Santotoribio JD, Delgado-Pecellín C, León-Justel A, Guerrero JM. Treatment indication with endothoracic drainage tube in parapneumonic effusions by partial pressure of carbon dioxide measurement in pleural fluid. Med Clinic. 2008;131:130–3.
Santotoribio JD, León-Justel A, Delgado-Pecellín C, Guerrero JM. What are the biochemical parameters of pleural fluid that best identify parapneumonic effusions? Ann Clin Biochem. 2009;46:176–7.
Bashour SI, Mankidy BJ, Lazarus DR. Update on the diagnosis and management of malignant pleural effusions. Respir Med. 2022;196: 106802.
Santotoribio JD, Sánchez-Linares P, Cabrera-Alarcón JL, Guerrero JM. Diagnostic value of carcinoembryonic antigen measurement in pleural fluid. Med Clin. 2010;135:574–5.
World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–4.
European Medicine Agency. Guideline for Good Clinical Practice: https://www.ema.europa.eu/en/ich-e6-r2-good-clinical-practice-scientific-guideline.
Block DR, Cotten SW, Franke D, Mbughuni MM. Comparison of five common analyzers in the measurement of chemistry analytes in an authentic cohort of body fluid specimens. Am J Clin Pathol. 2022;158:47–61.
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.
Antonangelo L, Faria CS, Sales RK. Tuberculous pleural effusion: diagnosis & management. Expert Rev Respir Med. 2019;13:747–59.
Shaw JA, Diacon AH, Koegelenberg CFN. Tuberculous pleural effusion. Respirology (Carlton, Vic). 2019;24:962–71.
Antonangelo L, Vargas FS, Genofre EH, Oliveira CM, Teixeira LR, Sales RK. Differentiating between tuberculosis-related and lymphoma-related lymphocytic pleural effusions by measuring clinical and laboratory variables: is it possible? J brasil de pneumola: publ oficial da Soc Brasil de Pneumol e Tisil. 2012;38:181–7.
Wang J, Liu J, Xie X, Shen P, He J, Zeng Y. The pleural fluid lactate dehydrogenase/adenosine deaminase ratio differentiates between tuberculous and parapneumonic pleural effusions. BMC Pulm Med. 2017;17:168.
Anar C, Yavuz MY, Alıcı İO, Güldaval F, Büyüksirin M. Diagnostic value of pleural fluid lactate dehydrogenase/adenosine deaminase ratio in differentiating parapneumonic effusion from tuberculous pleurisy. Egypt J Chest Dis Tubercul. 2021;70(4):547–53.
Vieira JL, Foschiera L, Ferreira ICS, Chakr VCBG. Performance of the quantification of adenosine deaminase and determination of the lactate dehydrogenase/adenosine deaminase ratio for the diagnosis of pleural tuberculosis in children and adolescents. J Brasil de Pneumol. 2021;47:e20200558.
Beukes A, Shaw JA, Diacon AH, Irusen EM, Koegelenberg CFN. The utility of pleural fluid lactate dehydrogenase to adenosine deaminase ratio in pleural tuberculosis. Respir Int Revf Thoracic Diseas. 2021;100:59–63.
Santotoribio JD, Cabrera-Alarcón JL, Batalha-Caetano P, Macher HC, Guerrero JM. Pleural fluid cell-free DNA in parapneumonic pleural effusion. Clin Biochem. 2015;48:1003–5.
Verma A, Abisheganaden J, Light RW. Identifying malignant pleural effusion by a cancer ratio (Serum LDH: Pleural Fluid ADA Ratio). Lung. 2016;194:147–53.
Verma A, Dagaonkar RS, Marshall D, Abisheganaden J, Light RW. Differentiating malignant from tubercular pleural effusion by cancer ratio plus (Cancer ratio: Pleural Lymphocyte Count). Can Respir J. 2016;2016:7348239.
Zhang Y, Li X, Liu J, et al. Diagnostic accuracy of the cancer ratio for the prediction of malignant pleural effusion: evidence from a validation study and meta-analysis. Ann Med. 2021;53:558–66.
Hackner K, Errhalt P, Handzhiev S. Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion. Ther Adv Med oncol. 2019;11:1758835919850341.
Trapé J, Sant F, Franquesa J, et al. Evaluation of two strategies for the interpretation of tumour markers in pleural effusions. Respir Res. 2017;18:103.
Santotoribio JD, Del Valle-Vazquez L, García-de la Torre A, Del Castillo-Otero D, Lopez-Saez JB, Sanchez Del Pino MJ. The diagnostic value of pleural fluid homocysteine in malignant pleural effusion. PLoS ONE. 2019;14:e0222616.
Chierakul N, Kanitsap A, Chaiprasert A, Viriyataveekul R. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion. Respirology (Carlton, Vic). 2004;9:66–9.
Vorster MJ, Allwood BW, Diacon AH, Koegelenberg CF. Tuberculous pleural effusions: advances and controversies. J Thorac Dis. 2015;7:981–91.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
Ph.D. DNJ: Conceptualization, data curation, formal analysis, methodology, investigation, writing—original draft, writing-review & editing. Ph.D. IRM: Data curation, formal analysis, writing—original draft. Ph.D. JMG-M: Writing—review & editing. Ph.D. JD. Santotoribio: Data curation, investigation, supervision, validation, writing—review & editing. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
There is no actual or potential conflict of interest for any author in relation with the results presented in the manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Núñez-Jurado, D., Rodríguez-Martín, I., Guerrero, J.M. et al. LDH/ADA ratio in pleural fluid for the diagnosis of infectious pleurisy. Clin Exp Med 23, 5201–5213 (2023). https://doi.org/10.1007/s10238-023-01194-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-023-01194-y